PriceTargets.com logo

Brookline Capital Management Stock Recommendations and Price Targets

This is a list of recent ratings by Brookline Capital Management.

DateCompany NameActionCurrent
Price		Price
Target		Rating
12/1/2025
IRD
Opus Genetics
 Upgrade$2.00Strong-Buy
11/3/2025
RNTX
Rein Therapeutics
 Upgrade$1.00Hold ➝ Buy
9/17/2025
CRDL
Cardiol Therapeutics
 Upgrade$1.00Strong-Buy
8/28/2025
IMAB
I-Mab
 Reiterated Rating$5.00Buy ➝ Buy
8/21/2025
BIOX
Bioceres Crop Solutions
 Downgrade$2.00Strong-Buy ➝ Hold
8/19/2025
RNTX
Rein Therapeutics
 Downgrade$1.00Buy ➝ Hold
8/13/2025
ICCM
IceCure Medical
 Reiterated Rating$1.00Buy ➝ Buy
7/21/2025
RADX
Radiopharm Theranostics
 Initiated Coverage$5.00 $18.00Buy
7/15/2025
LSTA
Lisata Therapeutics
 Boost Price Target$2.00$20.00 ➝ $32.00Buy ➝ Buy
7/9/2025
CADL
Candel Therapeutics
 Upgrade$5.00Strong-Buy
6/23/2025
HURA
TuHURA Biosciences
 Upgrade$2.00Strong-Buy
5/13/2025
PALI
Palisade Bio
 Reiterated Rating$2.00$16.00 ➝ $16.00Buy ➝ Buy
3/18/2025
BIVI
BioVie
 Upgrade$2.00Strong-Buy
3/11/2025
CRVO
CervoMed
 Upgrade$9.00Hold ➝ Strong-Buy
3/10/2025
CATX
Perspective Therapeutics
 Upgrade$2.00Strong-Buy
2/27/2025
IMAB
I-Mab
 Upgrade$5.00Strong-Buy
2/10/2025
MRKR
Marker Therapeutics
 Upgrade$1.00Strong-Buy
1/27/2025
CGTX
Cognition Therapeutics
 Upgrade$2.00Strong-Buy
12/23/2024
MDCX
Medicus Pharma
 Upgrade$2.00Strong-Buy
12/23/2024
EXEL
Exelixis
 Initiated Coverage$44.00Buy
12/18/2024
QNCX
Quince Therapeutics
 Initiated Coverage$4.00 $9.00Buy
12/10/2024
CRVO
CervoMed
 Downgrade$9.00Strong-Buy ➝ Hold
11/20/2024
PALI
Palisade Bio
 Initiated Coverage$2.00 $38.00Buy
11/15/2024
HYPD
Hyperion DeFi
 Reiterated Rating$4.00Buy ➝ Hold
11/13/2024
SYRS
Syros Pharmaceuticals
 Reiterated Rating$0.00Buy ➝ Hold
10/14/2024
COCH
Envoy Medical
 Initiated Coverage$1.00 $9.00Buy
10/2/2024
VRCA
Verrica Pharmaceuticals
 Reiterated Rating$8.00Buy ➝ Hold
8/22/2024
OSTX
OS Therapies
 Upgrade$2.00Strong-Buy
7/22/2024
IBIO
iBio
 Initiated Coverage$1.00 $3.60Buy
7/9/2024
UNCY
Unicycive Therapeutics
 Upgrade$6.00Strong-Buy
7/8/2024
CRVO
CervoMed
 Initiated Coverage$9.00 $63.00Buy
6/7/2024
SABS
SAB Biotherapeutics
 Initiated Coverage$4.00 $8.00Buy
5/30/2024
FBRX
Forte Biosciences
 Initiated Coverage$21.00 $4.00Buy
5/15/2024
DARE
Dare Bioscience
 Upgrade$2.00 $36.00Hold ➝ Buy
4/17/2024
DARE
Dare Bioscience
 Downgrade$2.00Buy ➝ Hold
4/5/2024
IMUX
Immunic
 Reiterated Rating$1.00 $10.00Buy
3/4/2024
ATBPF
Antibe Therapeutics
 Downgrade$0.00Buy ➝ Hold
2/28/2024
ANVS
Annovis Bio
 Downgrade$5.00 $9.00Buy ➝ Hold
1/25/2024
OTLK
Oncobiologics
 Upgrade$2.00 $31.40Hold ➝ Buy
12/7/2023
HEPA
Hepion Pharmaceuticals
 Downgrade$0.00Buy ➝ Hold
11/30/2023
LNTH
Lantheus
 Initiated Coverage$62.00 $100.00Buy
11/15/2023
SQZB
SQZ Biotechnologies
 Downgrade$0.00Buy ➝ Hold
11/10/2023
ANVS
Annovis Bio
 Reiterated Rating$5.00 $35.00Buy
10/30/2023
GNLX
Genelux
 Upgrade$5.00Hold ➝ Buy
10/17/2023
HYPD
Hyperion DeFi
 Initiated Coverage$4.00 $640.00Buy
10/12/2023
EDSA
Edesa Biotech
 Reiterated Rating$2.00 $57.00Buy ➝ Buy
8/30/2023
OTLK
Oncobiologics
 Downgrade$2.00Buy ➝ Hold
8/14/2023
ATBPF
Antibe Therapeutics
 Reiterated Rating$0.00Buy
2/14/2023
DARE
Dare Bioscience
 Reiterated Rating$2.00Buy
1/31/2023
HEPA
Hepion Pharmaceuticals
 Reiterated Rating$0.00Buy
1/12/2023
ECOR
electroCore
 Reiterated Rating$5.00Buy